Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis

NCT02393768 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02393768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis